I think you are right . I don't think NICE would care if they manufacture vaccine by artisan or fully automated method as long as it is validated and certified . Their main job is to recommend NHS of cost-benefit value of particular treatment (which MHRA has vetted and approved on clinical grounds) , and if it justifies particular cost, and if NHS should pay for it . I would think NW can submit appraisal based on Flaskworks right after approval and if they have to use artisan methods and sell at discount till EDEN/Flaskworks is up and validated , it is still better than delaying approval by 6-12 months.
Market Data 
Markets 
AI
